SEC-sourced researchBeta
BOLT
Bolt Biotherapeutics, Inc.
Company comparison ↗
Data passport
- CIK
- 0001641281
- Exchange
- Nasdaq
- Business activity
- Pharmaceutical Preparations · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Nov 17, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 7,690,000.0000 | Mar 12, 2026 |
| December 2025 | 7,695,000.0000 | Mar 12, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 7,695,000.0000 | -33,376,000.0000 | -39,850,000.0000 | 56,748,000.0000 | 30,243,000.0000 | Mar 12, 2026 |
| December 2024 | 7,690,000.0000 | -63,118,000.0000 | -61,289,000.0000 | 99,632,000.0000 | 42,434,000.0000 | Mar 12, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
39/100
Profitability0
Growth50
Balance sheet47
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $7.7M | Jan 1, 2025 – Dec 31, 2025 | Mar 12, 2026 | 10-K |
| Previous period revenueRevenues | $7.69M | Jan 1, 2024 – Dec 31, 2024 | Mar 12, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$33.38M | Jan 1, 2025 – Dec 31, 2025 | Mar 12, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$39.85M | Jan 1, 2025 – Dec 31, 2025 | Mar 12, 2026 | 10-K |
| Total assetsAssets | $56.75M | Dec 31, 2025 | Mar 12, 2026 | 10-K |
| Total liabilitiesLiabilities | $30.24M | Dec 31, 2025 | Mar 12, 2026 | 10-K |
New filings
- 4BOLT · Bolt Biotherapeutics, Inc.Nov 17, 2026 · Other
- 10-QBOLT · Bolt Biotherapeutics, Inc.Nov 13, 2026 · Periodic
- 8-KBOLT · Bolt Biotherapeutics, Inc.Nov 12, 2026 · Current event
- SCHEDULE 13G/ABOLT · Bolt Biotherapeutics, Inc.Nov 12, 2026 · Other
- 4BOLT · Bolt Biotherapeutics, Inc.Nov 10, 2026 · Other
- 3BOLT · Bolt Biotherapeutics, Inc.Nov 6, 2026 · Other
- SCHEDULE 13GBOLT · Bolt Biotherapeutics, Inc.Nov 6, 2026 · Other
- 4BOLT · Bolt Biotherapeutics, Inc.Oct 27, 2026 · Other
- 3BOLT · Bolt Biotherapeutics, Inc.Oct 27, 2026 · Other
- 8-KBOLT · Bolt Biotherapeutics, Inc.Oct 23, 2026 · Current event
- 8-KBOLT · Bolt Biotherapeutics, Inc.Oct 6, 2026 · Current event